Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -162.62KEnterprise Value
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 5.32M | $ 0 | $ -162.62K | $ 5.16M |
| 3/31/2025 | $ 2.46M | $ 0 | $ 3.34M | $ 5.79M |
| 12/31/2024 | $ 4.04M | $ 0 | $ 759.81K | $ 4.8M |
| 9/30/2024 | $ 6.51M | $ 0 | $ 214.33K | $ 6.73M |
| 6/30/2024 | $ 9.25M | $ 0 | $ -4.13M | $ 5.12M |
| 3/31/2024 | $ 1.95M | $ 30K | $ 2.4M | $ 4.32M |
| 12/31/2023 | $ 1.08M | $ 58K | $ 5.05M | $ 6.07M |
| 9/30/2023 | $ 2.66M | $ 92K | $ 7.79M | $ 10.35M |
| 6/30/2023 | $ 2.78M | $ 120K | $ 8.72M | $ 11.38M |
| 3/31/2023 | $ 2.05M | $ 147K | $ 9.32M | $ 11.22M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) EV stands at $ 37.07M.
- Over the past 5 years, GT BIOPHARMA INC's average EV has been $ 66.19M.
- The median EV for GT BIOPHARMA INC during this period was $ 10.46M
- GT BIOPHARMA INC reached its highest EV over the past 5 years at $ 332.29M.
- The lowest EV recorded by GT BIOPHARMA INC in the same timeframe $ -4.13M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for GT BIOPHARMA INC is calculated as follows: Market Cap [ $ 14.32M ] + Debt [ $ 23.11M ] - CashnEq [ $ 362K ]
(=) EV [ $ 37.07M ] GTBP - Enterprise Value, Last 5 years
$ -4.13M
Minimum
Jun 30, 2024
$ 332.29M
Maximum
Mar 31, 2021
$ 66.19M
Average
$ 10.46M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |